Doctor Anywhere, a Singapore-based regional tech-led healthcare company, raised US$65.7M in Series C financing.
The round was led by Asia Partners and also joined by Novo Holdings A/S, Philips Venture, OSK-SBI Ventures and existing investors Square Peg, EDBI, IHH Healthcare, Kamet Capital and Pavilion Capital. As a result of the financing, Dr Amit Kakar, Senior Partner, Head of Novo Holdings Equity Asia will join Doctor Anywhere’s Board of Directors and Carol Wang, Senior Associate, Novo Holdings Equity Asia will join the Board as an Observer.
The company intends to use the funds to bolster its market leadership, to further deepen its presence in its existing markets, and to expand into new markets.
Led by Lim Wai Mun, Founder and Chief Executive Officer, Doctor Anywhere combines technology and innovation to provide a digital platform that enables patients to access medical assistance on-demand anytime, without leaving their homes, whilst its offline platform provides users with access to resources such as GP clinics and mobile healthcare services. The company’s services allow for the management of a wide range of acute and chronic conditions in both adults and children, such as home-based health screenings and vaccinations, medication access and distribution, COVID-19 testing, mental wellness support, and nutrition and fitness counselling.
Since its launch in 2017, Doctor Anywhere has grown to serve more than 1.5 million users in Singapore and the wider region. It is currently available in Singapore, Malaysia, Thailand, Vietnam, and the Philippines. The group also recently announced the establishment of regional tech hubs in Bangalore, India, and Ho Chi Minh City, Vietnam.